Elevance Health kicked off 2025 by beating earnings expectations with an EPS of $11.97, flexing its operational muscles ...

Elevance Health's Q1 results showed stable Medicare utilization and reaffirmed guidance. Click here to find out why ELV stock ...

Supply chain company Owens & Minor released its right to sue over the BlueCard Program by participating in a $2.7 billion ...

In a report released today, Andrew Mok CFA from Barclays maintained a Buy rating on Elevance Health (ELV – Research Report), with a price ...

Barclays raised the firm’s price target on Elevance Health (ELV) to $522 from $512 and keeps an Overweight rating on the shares following the ...

FDA-cleared CureSight™ therapy now reimbursed by Elevance Health, expanding access to effective digital treatment for lazy ...

High Medicare Advantage spending continues to dog major carriers such as Elevance Health and UnitedHealth Group.

Elevance Health (ELV) stock slips amid pressure from UnitedHealth's (UNH) Q1 results, even as its own early Q1 2025 results ...

Strive Health, the national leader in value-based kidney care, announced today that it has expanded its executive team.

Glen Tullman, the CEO of Transcarent, is taking another big shot at transforming the U.S. health care system.

Fintel reports that on April 15, 2025, Baird downgraded their outlook for Elevance Health (NYSE:ELV) from Outperform to ...

Fintel reports that on April 9, 2025, Guggenheim initiated coverage of Elevance Health (NYSE:ELV) with a Buy recommendation. Analyst Price Forecast Suggests 16.21% Upside As of April 1, 2025, the ...